Placebo matching survodutide

COMBINATION_PRODUCT2 trials

Sponsors

Boehringer Ingelheim

Conditions

Metabolic Dysfunction Associated SteatohepatitisObesity

Phase 3

A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease

CompletedNCT06176365

Boehringer IngelheimObesity

Start: 2024-01-16End: 2025-12-03Updated: 2026-04-30

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

RecruitingNCT06632457

Boehringer IngelheimMetabolic Dysfunction Associated Steatohepatitis

Start: 2024-11-12End: 2029-06-05Target: 1590Updated: 2026-09-18

Related Papers

Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 <scp>SYNCHRONIZE</scp> ‐ <scp>JP</scp> Trial

Diabetes Obesity and Metabolism2026-05-31